Selective blockade of the lyso-PS lipase ABHD12 stimulates immune responses in vivo

ABHD12 metabolizes bioactive lysophospholipids, including lysophosphatidylserine (lyso-PS). Deleterious mutations in human ABHD12 cause the neurological disease PHARC, and ABHD12(−/−) mice display PHARC-like phenotypes, including hearing loss, along with elevated brain lyso-PS and features of stimul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasawara, Daisuke, Aki-Ichu, Taka, Vartabedian, Vincent, Benthuysen, Jacqueline, Jing, Hui, Reed, Alex, Ulanovskaya, Olesya, Hulce, Jonathan J., Roberts, Amanda, Brown, Steven, Rosen, Hugh, Teijaro, John R., Cravatt, Benjamin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263940/
https://www.ncbi.nlm.nih.gov/pubmed/30420694
http://dx.doi.org/10.1038/s41589-018-0155-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263940/
https://www.ncbi.nlm.nih.gov/pubmed/30420694
http://dx.doi.org/10.1038/s41589-018-0155-8

Ejemplares similares